Literature DB >> 11083506

Neurological complications of essential thrombocytosis (ET).

A Kesler1, M H Ellis, Y Manor, N Gadoth, M Lishner.   

Abstract

OBJECTIVE: To evaluate the prevalence of neurological abnormalities in patients with ET and attempt to identify risk factors for neurological complications.
METHOD: Ninety-five patient charts were reviewed from January 1983-July 1999. Seventy patients fulfilled the Polycythemia Vera Study Group criteria for diagnosing ET.
RESULTS: Eighteen patients (25.7%) had episodes of neurological impairment, 52 (74.3%) had none. Neurological features-- occlusive cerebrovascular event-9; chronic headache-3 and dizziness-3, mononeuritis multiplex, sinus vein thrombosis and epilepsy-1 each. The interval between diagnosis of ET and occurrence of neurological events ranged from time of presentation (10 patients) to 13 years (1 patient) with a high predominance of females, 88.8% and 55%, respectively.
CONCLUSIONS: Neurological complications occurred at presentation or during follow-up in approximately 25% of patients with ET. Our observation suggests that further investigation focusing on the possible mechanisms for neurological deficits in females with ET should be considered.

Entities:  

Mesh:

Year:  2000        PMID: 11083506     DOI: 10.1034/j.1600-0404.2000.102005299.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  4 in total

1.  Neurological disorders in essential thrombocythemia.

Authors:  Segolene Billot; Eirini G Kouroupi; Johan Le Guilloux; Bruno Cassinat; Caroline Jardin; Thierry Laperche; Pierre Fenaux; Antoine F Carpentier; Jean-Jacques Kiladjian
Journal:  Haematologica       Date:  2011-09-20       Impact factor: 9.941

2.  Open-label, dose-titration and continuation study to assess efficacy, safety, and pharmacokinetics of anagrelide in treatment-naïve Japanese patients with essential thrombocythemia.

Authors:  Shinichiro Okamoto; Yoshitaka Miyakawa; Jonathan Smith; Ian Hodgson; Brihad Abhyankar; Steven Troy; Yuzuru Kanakura
Journal:  Int J Hematol       Date:  2013-02-03       Impact factor: 2.490

Review 3.  Medical and Nonstroke Neurologic Causes of Acute, Continuous Vestibular Symptoms.

Authors:  Jonathan A Edlow; David E Newman-Toker
Journal:  Neurol Clin       Date:  2015-08       Impact factor: 3.787

Review 4.  Headache in essential thrombocythaemia.

Authors:  R Frewin; A Dowson
Journal:  Int J Clin Pract       Date:  2012-08-14       Impact factor: 2.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.